Esperion Therapeutics, Inc. (ESPR)

  • 2021-12-08 16:00:02
  • PRE
  • NasdaqGM
  • Nasdaq Real Time Price
  • USD
Last
5.87 +0.31 (+5.58%)
Volume
3,043,992
52 Week Range
4.96 - 39.49
 
Key Stats
Open 5.62
Day High 5.91
Day Low 5.52
Previous Close 5.56
52 Week High 39.49
52 Week Low 4.96
50 Day Average 9.10
200 Day Average 17.98
Market Cap 177.1M
Shares Out 30.2M
Book Value -13.53
Ratios/Profitability
EPS -11.69
P/E -
P/B -0.43
Events
Earnings Date 2021-11-02
Technical Indicators (Daily)
RSI(14) 38.30
STOCH(14) 17.98
AROON(25) -84.00
SD(21) 5.13
MA(50) 9.10
EMA(50) 9.24
MACD(12,26) -0.91
SIGNAL -0.67
DIVERGENCE -0.24
About

Esperion Therapeutics, Inc. is a public American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.

Latest News
Esperion Announces Closing of $225 Million Public Offering
Tue, 07 Dec 2021 21:05:00 +0000

ANN ARBOR, Mich., Dec. 07, 2021 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) (“Esperion” or the “Company”), today announced the closing of its previously announced underwritten public offering ...

Esperion Announces Pricing of $225 Million Public Offering
Fri, 03 Dec 2021 04:40:00 +0000

ANN ARBOR, Mich., Dec. 02, 2021 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) (“Esperion” or the “Company”), today announced the pricing of its previously announced underwritten public offering ...

Esperion Announces Proposed Public Offering
Thu, 02 Dec 2021 22:00:00 +0000

ANN ARBOR, Mich., Dec. 02, 2021 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) (“Esperion” or the “Company”), today announced that it intends to offer and sell, subject to market and other condit...

Latest Comments

Related Stocks

Disclaimer: The data contained in Super Surge website is not necessarily real-time nor accurate and may differ from the actual market data. Prices, volumes, ratios, charts and indicators are indicative and not appropriate for trading purposes. Super Surge doesn't bear any responsibility for any trading losses you might incur as a result of using this data.